A pilot dose finding study of pioglitazone in autistic children

BACKGROUND: Pioglitazone is a promising compound for treatment of core autism spectrum disorder (ASD) symptoms as it targets multiple relevant pathways, including immune system alterations. OBJECTIVE: This pilot study aimed to elucidate the maximum tolerated dose, safety, preliminary evidence of eff...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Mol Autism
Главные авторы: Capano, Lucia, Dupuis, Annie, Brian, Jessica, Mankad, Deepali, Genore, Lisa, Hastie Adams, Rianne, Smile, Sharon, Lui, Toni, Odrobina, Dina, Foster, Jane A., Anagnostou, Evdokia
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2018
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6258310/
https://ncbi.nlm.nih.gov/pubmed/30498564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13229-018-0241-5
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы